Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200000 participants
OBSERVATIONAL
2022-12-28
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Cohort of COVID-19 Patients in Hubei Province
NCT05615792
Respiratory Virus Metagenomics After COVID-19
NCT05126589
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
NCT06349707
Microecology and Host Immunity in Patients With Severe COVID-19 Infection
NCT05670275
Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong
NCT04325919
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 Infection
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LingTao
Professor in Cardiology, Director of the department of Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ling Tao, MD, Ph.D.
Role: STUDY_CHAIR
Xijing Hospital
Chao Gao, MD, Ph.D.
Role: STUDY_CHAIR
Xijing Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ling Tao
Xi'an, Shannxi, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Survey of COVID-19 infection
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.